查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
癌症活體組織切片市場（產品：平台和儀器、套件和試劑以及服務；類型：組織活體組織切片、液體活體組織切片和其他）- 2023-2031年全球行業分析、規模、佔有率、成長、趨勢和預測
市場調查報告書
商品編碼
1301441

癌症活體組織切片市場（產品：平台和儀器、套件和試劑以及服務；類型：組織活體組織切片、液體活體組織切片和其他）- 2023-2031年全球行業分析、規模、佔有率、成長、趨勢和預測

Cancer Biopsy Market (Product: Platforms & Instruments, Kits & Reagents, and Services; Type: Tissue Biopsies, Liquid Biopsies, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 190 Pages | 商品交期: 2-10個工作天內

價格

癌症活體組織切片市場- 報告的範圍

TMR關於全球癌症活體組織切片市場的報告研究了過去以及當前的成長趨勢和機會，以獲得對2023年至2031年預測期間市場指標的寶貴見解。報告提供了2017-2031年期間全球癌症活體組織切片市場的收入，考慮到2023年為基準年，2031年為預測年。報告還提供了2023年至2031年全球癌症活體組織切片市場的複合年成長率（CAGR %）。

該報告是在廣泛的研究後編寫的。一級研究涉及大部分的研究工作，其中分析師與關鍵意見領袖、行業領袖和意見製造者進行了訪談。二級研究包括參考主要參與者的產品資料、年度報告、新聞稿和相關文件，以了解癌症活體組織切片市場。

該報告深入研究了癌症活體組織切片的競爭格局。在全球癌症活體組織切片市場運作的主要參與者已被確定，其中每一個都在各種屬性方面進行了分析。公司概況、財務狀況、近期發展和SWOT是本報告對全球癌症活體組織切片市場參與者的屬性描述。

目錄

第一章：前言

  • 市場定義和範圍
  • 市場細分
  • 主要研究目標
  • 研究重點

第二章：假設和研究方法

第三章：執行摘要：全球市場

第四章：市場概述

  • 簡介
    • 細分市場的定義
  • 概述
  • 市場動態
    • 驅動力
    • 限制因素
    • 機會
  • 2017-2031年全球市場分析和預測
    • 市場收入預測

第五章：關鍵洞察力

  • 癌症患病率和發病率：按地區分類
  • 技術進步
  • COVID-19大流行對行業的影響（價值鍊和短期/中期/長期影響）。
  • 各地區/全球的報銷情況
  • 價值鏈分析

第六章：全球市場分析與預測：按產品分類

  • 介紹和定義
  • 主要發現/發展
  • 市場價值預測：按產品分類，2017-2031年
    • 平台和儀器
    • 套件和試劑
    • 服務
  • 市場吸引力分析：按產品分類

第七章：全球市場分析和預測：按類型

  • 介紹和定義
  • 主要研究結果/發展
  • 市場價值預測：按類型，2017-2031年
    • 組織活體組織切片
      • 針刺活體組織切片
      • 手術活體組織切片
    • 液體活體組織切片
    • 其他類型
  • 市場吸引力分析：按類型

第八章：全球市場分析與預測：按應用分類

  • 介紹和定義
  • 主要研究結果/發展
  • 市場價值預測：按應用分類，2017-2031年
    • 乳腺癌
    • 結直腸癌
    • 宮頸癌
    • 肺癌
    • 前列腺癌
    • 皮膚癌
    • 血癌
    • 腎癌
    • 肝癌
    • 胰腺癌
    • 卵巢癌
    • 其他
  • 市場吸引力分析：按應用分類

第九章：全球市場分析與預測：按地區分類

  • 主要發現
  • 市場價值預測：按地區分類，2017-2031年
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力分析：按地區

第十章：北美市場分析與預測

  • 簡介
    • 主要發現
  • 市場價值預測：按產品分類，2017-2031年
    • 平台和儀器
    • 套件和試劑
    • 服務
  • 市場價值預測：按類型分類，2017-2031年
    • 組織活體組織切片
      • 針刺活體組織切片
      • 手術活體組織切片
    • 液體活體組織切片
    • 其他類型
  • 市場價值預測：按應用分類，2017-2031年
    • 乳腺癌
    • 結直腸癌
    • 宮頸癌
    • 肺癌
    • 前列腺癌
    • 皮膚癌
    • 血癌
    • 腎癌
    • 肝癌
    • 胰腺癌
    • 卵巢癌
    • 其他癌症
  • 市場價值預測：按國家分類，2017-2031年
    • 美國
    • 加拿大
  • 市場吸引力分析
    • 按產品分類
    • 按類型
    • 按應用分類
    • 按國家分類

第11章：歐洲市場分析和預測

  • 簡介
    • 主要發現
  • 市場價值預測：按產品，2017-2031年
    • 平台和儀器
    • 套件和試劑
    • 服務
  • 市場價值預測：按類型分類，2017-2031年
    • 組織活體組織切片
      • 針刺活體組織切片
      • 手術活體組織切片
    • 液體活體組織切片
    • 其他類型
  • 市場價值預測：按應用分類，2017-2031年
    • 乳腺癌
    • 結直腸癌
    • 宮頸癌
    • 肺癌
    • 前列腺癌
    • 皮膚癌
    • 血癌
    • 腎癌
    • 肝癌
    • 胰腺癌
    • 卵巢癌
    • 其他癌症
  • 市場價值預測：按國家/次區域，2017-2031年
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 市場吸引力分析
    • 按產品分類
    • 按類型
    • 按應用分類
    • 按國家/次區域分類

第十二章：亞太地區市場分析和預測

  • 簡介
    • 主要發現
  • 市場價值預測：按產品，2017-2031年
    • 儀器
    • 試劑盒和試劑
    • 服務
  • 市場價值預測：按類型分類，2017-2031年
    • 組織活體組織切片
      • 針刺活體組織切片
      • 手術活體組織切片
    • 液體活體組織切片
    • 其他類型
  • 市場價值預測：按應用分類，2017-2031年
    • 乳腺癌
    • 結直腸癌
    • 宮頸癌
    • 肺癌
    • 前列腺癌
    • 皮膚癌
    • 血癌
    • 腎癌
    • 肝癌
    • 胰腺癌
    • 卵巢癌
    • 其他癌症
  • 市場價值預測：按國家/次區域分類，2017-2031年
    • 中國
    • 日本
    • 印度
    • 澳大利亞和新西蘭
    • 亞太其他地區
  • 市場吸引力分析
    • 按產品分類
    • 按類型
    • 按應用分類
    • 按國家/次區域分類

第13章：拉丁美洲市場分析與預測

  • 簡介
    • 主要發現
  • 市場價值預測：按產品，2017-2031年
    • 平台&平台&儀器
    • 套件和試劑
    • 服務
  • 市場價值預測：按類型，2017-2031年
    • 組織活體組織切片
      • 針刺活體組織切片
      • 手術活體組織切片
    • 液體活體組織切片
    • 其他類型
  • 市場價值預測：按應用分類，2017-2031年
    • 乳腺癌
    • 結直腸癌
    • 宮頸癌
    • 肺癌
    • 前列腺癌
    • 皮膚癌
    • 血癌
    • 腎癌
    • 肝癌
    • 胰腺癌
    • 卵巢癌
    • 其他癌症
  • 市場價值預測：按國家/次區域，2017-2031年
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區
  • 市場吸引力分析
    • 按產品分類
    • 按類型
    • 按應用分類
    • 按國家/次區域分類

第十四章：中東和非洲市場分析和預測

  • 介紹
    • 主要發現
  • 市場價值預測：按產品，2017-2031年
    • 平台和儀器
    • 套件和試劑
    • 服務
  • 市場價值預測：按類型分類，2017-2031年
    • 組織活體組織切片
      • 針刺活體組織切片
      • 手術活體組織切片
    • 液體活體組織切片
    • 其他類型
  • 市場價值預測：按應用分類，2017-2031年
    • 乳腺癌
    • 結直腸癌
    • 宮頸癌
    • 肺癌
    • 前列腺癌
    • 皮膚癌
    • 血癌
    • 腎癌
    • 肝癌
    • 胰腺癌
    • 卵巢癌
    • 其他癌症
  • 市場價值預測：按國家/次區域分類，2017-2031年
    • 海灣合作理事會國家
    • 南非
    • 中東和非洲其他地區
  • 市場吸引力分析
    • 按產品分類
    • 按類型
    • 按應用分類
    • 按國家/次區域分類

第十五章：競爭格局

  • 市場參與者- 競爭矩陣（按公司層級和規模）。
  • 市場佔有率分析：按公司分類，2022年
  • 公司簡介
    • Abbott Laboratories
    • Becton, Dickinson and Company
    • F. Hoffmann-La Roche Ltd.
    • Hologic, Inc.
    • Danaher Corporation
    • Thermo Fisher Scientific, Inc.
    • Agilent Technologies, Inc.
    • Illumina, Inc.
    • Siemens Healthineers
    • GE Healthcare
    • Bio-Rad Laboratories, Inc.
    • Olympus Corporation
    • QIAGEN
Product Code: TMRGL85628

Cancer Biopsy Market - Scope of Report

TMR's report on the global Cancer Biopsy Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global Cancer Biopsy Market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Cancer Biopsy Market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Cancer Biopsy market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the Cancer Biopsy.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the Cancer Biopsy. These serve as valuable tools for existing market players as well as for entities interested in participating in the Cancer Biopsy.

The report delves into the competitive landscape of the Cancer Biopsy. Key players operating in the global Cancer Biopsy Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Cancer Biopsy Market profiled in this report.

Key Questions Answered in Global Cancer Biopsy Market Report:

  • What is the sales/revenue generated by Cancer Biopsy across all regions during the forecast period?
  • What are the opportunities in the Cancer Biopsy?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Cancer Biopsy Market - Research Objectives and Research Approach

The comprehensive report on the global Cancer Biopsy Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Cancer Biopsy Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the Cancer Biopsy.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Cancer Biopsy Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Cancer Biopsy Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Cancer Prevalence & Incidence, by Region
  • 5.2. Technological Advancements
  • 5.3. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)
  • 5.4. Reimbursement Scenario by Region/Globally
  • 5.5. Value Chain Analysis

6. Global Cancer Biopsy Market Analysis and Forecast, by Product

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product, 2017-2031
    • 6.3.1. Platforms & Instruments
    • 6.3.2. Kits & Reagents
    • 6.3.3. Services
  • 6.4. Market Attractiveness Analysis, by Product

7. Global Cancer Biopsy Market Analysis and Forecast, by Type

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Type, 2017-2031
    • 7.3.1. Tissue Biopsies
      • 7.3.1.1. Needle Biopsies
      • 7.3.1.2. Surgical Biopsies
    • 7.3.2. Liquid Biopsies
    • 7.3.3. Others
  • 7.4. Market Attractiveness Analysis, by Type

8. Global Cancer Biopsy Market Analysis and Forecast, by Application

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Application, 2017-2031
    • 8.3.1. Breast Cancer
    • 8.3.2. Colorectal Cancer
    • 8.3.3. Cervical Cancer
    • 8.3.4. Lung Cancer
    • 8.3.5. Prostate Cancer
    • 8.3.6. Skin Cancer
    • 8.3.7. Blood Cancer
    • 8.3.8. Kidney Cancer
    • 8.3.9. Liver Cancer
    • 8.3.10. Pancreatic Cancer
    • 8.3.11. Ovarian Cancer
    • 8.3.12. Others
  • 8.4. Market Attractiveness Analysis, by Application

9. Global Cancer Biopsy Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2017-2031
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Cancer Biopsy Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Product, 2017-2031
    • 10.2.1. Platforms & Instruments
    • 10.2.2. Kits & Reagents
    • 10.2.3. Services
  • 10.3. Market Value Forecast, by Type, 2017-2031
    • 10.3.1. Tissue Biopsies
      • 10.3.1.1. Needle Biopsies
      • 10.3.1.2. Surgical Biopsies
    • 10.3.2. Liquid Biopsies
    • 10.3.3. Others
  • 10.4. Market Value Forecast, by Application, 2017-2031
    • 10.4.1. Breast Cancer
    • 10.4.2. Colorectal Cancer
    • 10.4.3. Cervical Cancer
    • 10.4.4. Lung Cancer
    • 10.4.5. Prostate Cancer
    • 10.4.6. Skin Cancer
    • 10.4.7. Blood Cancer
    • 10.4.8. Kidney Cancer
    • 10.4.9. Liver Cancer
    • 10.4.10. Pancreatic Cancer
    • 10.4.11. Ovarian Cancer
    • 10.4.12. Others
  • 10.5. Market Value Forecast, by Country, 2017-2031
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Product
    • 10.6.2. By Type
    • 10.6.3. By Application
    • 10.6.4. By Country

11. Europe Cancer Biopsy Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product, 2017-2031
    • 11.2.1. Platforms & Instruments
    • 11.2.2. Kits & Reagents
    • 11.2.3. Services
  • 11.3. Market Value Forecast, by Type, 2017-2031
    • 11.3.1. Tissue Biopsies
      • 11.3.1.1. Needle Biopsies
      • 11.3.1.2. Surgical Biopsies
    • 11.3.2. Liquid Biopsies
    • 11.3.3. Others
  • 11.4. Market Value Forecast, by Application, 2017-2031
    • 11.4.1. Breast Cancer
    • 11.4.2. Colorectal Cancer
    • 11.4.3. Cervical Cancer
    • 11.4.4. Lung Cancer
    • 11.4.5. Prostate Cancer
    • 11.4.6. Skin Cancer
    • 11.4.7. Blood Cancer
    • 11.4.8. Kidney Cancer
    • 11.4.9. Liver Cancer
    • 11.4.10. Pancreatic Cancer
    • 11.4.11. Ovarian Cancer
    • 11.4.12. Others
  • 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Product
    • 11.6.2. By Type
    • 11.6.3. By Application
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Cancer Biopsy Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product, 2017-2031
    • 12.2.1. Instruments
    • 12.2.2. Kits & Reagents
    • 12.2.3. Services
  • 12.3. Market Value Forecast, by Type, 2017-2031
    • 12.3.1. Tissue Biopsies
      • 12.3.1.1. Needle Biopsies
      • 12.3.1.2. Surgical Biopsies
    • 12.3.2. Liquid Biopsies
    • 12.3.3. Others
  • 12.4. Market Value Forecast, by Application, 2017-2031
    • 12.4.1. Breast Cancer
    • 12.4.2. Colorectal Cancer
    • 12.4.3. Cervical Cancer
    • 12.4.4. Lung Cancer
    • 12.4.5. Prostate Cancer
    • 12.4.6. Skin Cancer
    • 12.4.7. Blood Cancer
    • 12.4.8. Kidney Cancer
    • 12.4.9. Liver Cancer
    • 12.4.10. Pancreatic Cancer
    • 12.4.11. Ovarian Cancer
    • 12.4.12. Others
  • 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Product
    • 12.6.2. By Type
    • 12.6.3. By Application
    • 12.6.4. By Country/Sub-region

13. Latin America Cancer Biopsy Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product, 2017-2031
    • 13.2.1. Platforms & Platforms & Instruments
    • 13.2.2. Kits & Reagents
    • 13.2.3. Services
  • 13.3. Market Value Forecast, by Type, 2017-2031
    • 13.3.1. Tissue Biopsies
      • 13.3.1.1. Needle Biopsies
      • 13.3.1.2. Surgical Biopsies
    • 13.3.2. Liquid Biopsies
    • 13.3.3. Others
  • 13.4. Market Value Forecast, by Application, 2017-2031
    • 13.4.1. Breast Cancer
    • 13.4.2. Colorectal Cancer
    • 13.4.3. Cervical Cancer
    • 13.4.4. Lung Cancer
    • 13.4.5. Prostate Cancer
    • 13.4.6. Skin Cancer
    • 13.4.7. Blood Cancer
    • 13.4.8. Kidney Cancer
    • 13.4.9. Liver Cancer
    • 13.4.10. Pancreatic Cancer
    • 13.4.11. Ovarian Cancer
    • 13.4.12. Others
  • 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Product
    • 13.6.2. By Type
    • 13.6.3. By Application
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Cancer Biopsy Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product, 2017-2031
    • 14.2.1. Platforms & Instruments
    • 14.2.2. Kits & Reagents
    • 14.2.3. Services
  • 14.3. Market Value Forecast, by Type, 2017-2031
    • 14.3.1. Tissue Biopsies
      • 14.3.1.1. Needle Biopsies
      • 14.3.1.2. Surgical Biopsies
    • 14.3.2. Liquid Biopsies
    • 14.3.3. Others
  • 14.4. Market Value Forecast, by Application, 2017-2031
    • 14.4.1. Breast Cancer
    • 14.4.2. Colorectal Cancer
    • 14.4.3. Cervical Cancer
    • 14.4.4. Lung Cancer
    • 14.4.5. Prostate Cancer
    • 14.4.6. Skin Cancer
    • 14.4.7. Blood Cancer
    • 14.4.8. Kidney Cancer
    • 14.4.9. Liver Cancer
    • 14.4.10. Pancreatic Cancer
    • 14.4.11. Ovarian Cancer
    • 14.4.12. Others
  • 14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Product
    • 14.6.2. By Type
    • 14.6.3. By Application
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (by tier and size of companies)
  • 15.2. Market Share Analysis, by Company, 2022
  • 15.3. Company Profiles
    • 15.3.1. Abbott Laboratories
      • 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. Financial Overview
      • 15.3.1.4. SWOT Analysis
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Becton, Dickinson and Company
      • 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. Financial Overview
      • 15.3.2.4. SWOT Analysis
      • 15.3.2.5. Strategic Overview
    • 15.3.3. F. Hoffmann-La Roche Ltd.
      • 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. Financial Overview
      • 15.3.3.4. SWOT Analysis
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Hologic, Inc.
      • 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. Financial Overview
      • 15.3.4.4. SWOT Analysis
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Danaher Corporation
      • 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. Financial Overview
      • 15.3.5.4. SWOT Analysis
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Thermo Fisher Scientific, Inc.
      • 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. Financial Overview
      • 15.3.6.4. SWOT Analysis
      • 15.3.6.5. Strategic Overview
    • 15.3.7. Agilent Technologies, Inc.
      • 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. Financial Overview
      • 15.3.7.4. SWOT Analysis
      • 15.3.7.5. Strategic Overview
    • 15.3.8. Illumina, Inc.
      • 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. Financial Overview
      • 15.3.8.4. SWOT Analysis
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Siemens Healthineers
      • 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. Financial Overview
      • 15.3.9.4. SWOT Analysis
      • 15.3.9.5. Strategic Overview
    • 15.3.10. GE Healthcare
      • 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.10.2. Product Portfolio
      • 15.3.10.3. Financial Overview
      • 15.3.10.4. SWOT Analysis
      • 15.3.10.5. Strategic Overview
    • 15.3.11. Bio-Rad Laboratories, Inc.
      • 15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.11.2. Product Portfolio
      • 15.3.11.3. Financial Overview
      • 15.3.11.4. SWOT Analysis
      • 15.3.11.5. Strategic Overview
    • 15.3.12. Olympus Corporation
      • 15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.12.2. Product Portfolio
      • 15.3.12.3. Financial Overview
      • 15.3.12.4. SWOT Analysis
      • 15.3.12.5. Strategic Overview
    • 15.3.13. QIAGEN
      • 15.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.13.2. Product Portfolio
      • 15.3.13.3. Financial Overview
      • 15.3.13.4. SWOT Analysis
      • 15.3.13.5. Strategic Overview

List of Tables

  • Table 01: Global Cancer Biopsy Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 02: Global Cancer Biopsy Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 03: Global Cancer Biopsy Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 04: Global Cancer Biopsy Market Value (US$ Mn) Forecast, by Tissue Biopsies, 2017-2031
  • Table 05: Global Cancer Biopsy Market Value (US$ Mn) Forecast, by Liquid Biopsies, 2017-2031
  • Table 06: Global Cancer Biopsy Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 07: North America Cancer Biopsy Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 08: North America Cancer Biopsy Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 09: North America Cancer Biopsy Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 10: North America Cancer Biopsy Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 11: North America Cancer Biopsy Market Value (US$ Mn) Forecast, by Tissue Biopsies, 2017-2031
  • Table 12: North America Cancer Biopsy Market Value (US$ Mn) Forecast, by Liquid Biopsies, 2017-2031
  • Table 13: Europe Cancer Biopsy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: Europe Cancer Biopsy Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 15: Europe Cancer Biopsy Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 16: Europe Cancer Biopsy Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 17: Europe Cancer Biopsy Market Value (US$ Mn) Forecast, by Tissue Biopsies, 2017-2031
  • Table 18: Europe Cancer Biopsy Market Value (US$ Mn) Forecast, by Liquid Biopsies, 2017-2031
  • Table 19: Asia Pacific Cancer Biopsy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 20: Asia Pacific Cancer Biopsy Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 21: Asia Pacific Cancer Biopsy Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 22: Asia Pacific Cancer Biopsy Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 23: Asia Pacific Cancer Biopsy Market Value (US$ Mn) Forecast, by Tissue Biopsies, 2017-2031
  • Table 24: Asia Pacific Cancer Biopsy Market Value (US$ Mn) Forecast, by Liquid Biopsies, 2017-2031
  • Table 25: Latin America Cancer Biopsy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 26: Latin America Cancer Biopsy Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 27: Latin America Cancer Biopsy Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 28: Latin America Cancer Biopsy Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 29: Latin America Cancer Biopsy Market Value (US$ Mn) Forecast, by Tissue Biopsies, 2017-2031
  • Table 30: Latin America Cancer Biopsy Market Value (US$ Mn) Forecast, by Liquid Biopsies, 2017-2031
  • Table 31: Middle East & Africa Cancer Biopsy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 32: Middle East & Africa Cancer Biopsy Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 33: Middle East & Africa Cancer Biopsy Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 34: Middle East & Africa Cancer Biopsy Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 35: Middle East & Africa Cancer Biopsy Market Value (US$ Mn) Forecast, by Tissue Biopsies, 2017-2031
  • Table 36: Middle East & Africa Cancer Biopsy Market Value (US$ Mn) Forecast, by Liquid Biopsies, 2017-2031

List of Figures

  • Figure 01: Global Cancer Biopsy Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 02: Global Cancer Biopsy Market Attractiveness Analysis, Product, 2023-2031
  • Figure 03: Global Cancer Biopsy Market Revenue (US$ Mn), by Platforms & Instruments, 2017-2031
  • Figure 04: Global Cancer Biopsy Market Revenue (US$ Mn), by Kits & Reagents, 2017-2031
  • Figure 04: Global Cancer Biopsy Market Revenue (US$ Mn), by Services, 2017-2031
  • Figure 05: Global Cancer Biopsy Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 06: Global Cancer Biopsy Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 07: Global Cancer Biopsy Market Revenue (US$ Mn), by Tissue Biopsies, 2017-2031
  • Figure 08: Global Cancer Biopsy Market Revenue (US$ Mn), by Liquid Biopsies, 2017-2031
  • Figure 09: Global Cancer Biopsy Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 10: Global Cancer Biopsy Market Attractiveness Analysis, Application, 2023-2031
  • Figure 11: Global Cancer Biopsy Market Revenue (US$ Mn), by Breast Cancer, 2017-2031
  • Figure 12: Global Cancer Biopsy Market Revenue (US$ Mn), by Colorectal Cancer, 2017-2031
  • Figure 13: Global Cancer Biopsy Market Revenue (US$ Mn), by Cervical Cancer 2022 and 2031
  • Figure 14: Global Cancer Biopsy Market Revenue (US$ Mn), Lung Cancer, 2023-2031
  • Figure 15: Global Cancer Biopsy Market Revenue (US$ Mn), by Prostate Cancer, 2017-2031
  • Figure 16: Global Cancer Biopsy Market Revenue (US$ Mn), by Skin Cancer, 2017-2031
  • Figure 17: Global Cancer Biopsy Market Revenue (US$ Mn), by Blood Cancer, 2017-2031
  • Figure 18: Global Cancer Biopsy Market Revenue (US$ Mn), Kidney Cancer, 2023-2031
  • Figure 19: Global Cancer Biopsy Market Revenue (US$ Mn), by Liver Cancer, 2017-2031
  • Figure 20: Global Cancer Biopsy Market Revenue (US$ Mn), by Pancreatic Cancer, 2017-2031
  • Figure 21: Global Cancer Biopsy Market Revenue (US$ Mn), by Ovarian Cancer, 2017-2031
  • Figure 22: Global Cancer Biopsy Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 23: Global Cancer Biopsy Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 24: Global Cancer Biopsy Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 25: North America Cancer Biopsy Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 26: North America Cancer Biopsy Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 27: North America Cancer Biopsy Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 28: North America Cancer Biopsy Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 29: North America Cancer Biopsy Market Attractiveness Analysis, Product, 2023-2031
  • Figure 30: North America Cancer Biopsy Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 31: North America Cancer Biopsy Market Attractiveness Analysis, Type, 2023-2031
  • Figure 32: North America Cancer Biopsy Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 33: North America Cancer Biopsy Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 34: Europe Cancer Biopsy Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 35: Europe Cancer Biopsy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 36: Europe Cancer Biopsy Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 37: Europe Cancer Biopsy Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 38: Europe Cancer Biopsy Market Attractiveness Analysis, Product, 2023-2031
  • Figure 39: Europe Cancer Biopsy Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 40: Europe Cancer Biopsy Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 41: Europe Cancer Biopsy Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 42: Europe Cancer Biopsy Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 43: Asia Pacific Cancer Biopsy Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 44: Asia Pacific Cancer Biopsy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 45: Asia Pacific Cancer Biopsy Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 46: Asia Pacific Cancer Biopsy Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 47: Asia Pacific Cancer Biopsy Market Attractiveness Analysis, Product, 2023-2031
  • Figure 48: Asia Pacific Cancer Biopsy Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 49: Asia Pacific Cancer Biopsy Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 50: Asia Pacific Cancer Biopsy Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 51: Asia Pacific Cancer Biopsy Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 52: Latin America Cancer Biopsy Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 53: Latin America Cancer Biopsy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 54: Latin America Cancer Biopsy Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 55: Latin America Cancer Biopsy Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 56: Latin America Cancer Biopsy Market Attractiveness Analysis, Product, 2023-2031
  • Figure 57: Latin America Cancer Biopsy Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 58: Latin America Cancer Biopsy Market Attractiveness Analysis, Type, 2023-2031
  • Figure 59: Latin America Cancer Biopsy Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 60: Latin America Cancer Biopsy Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 61: Middle East & Africa Cancer Biopsy Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 62: Middle East & Africa Cancer Biopsy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 63: Middle East & Africa Cancer Biopsy Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 64: Middle East & Africa Cancer Biopsy Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 65: Middle East & Africa Cancer Biopsy Market Attractiveness Analysis, Product, 2023-2031
  • Figure 66: Middle East & Africa Cancer Biopsy Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 67: Middle East & Africa Cancer Biopsy Market Attractiveness Analysis, Type, 2023-2031
  • Figure 68: Middle East & Africa Cancer Biopsy Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 69: Middle East & Africa Cancer Biopsy Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 70: Global Cancer Biopsy Market Share Analysis, by Company 2022